Webcast CME

Series - Allergy / Immunology

Advances in Biologic Therapies
Advances in Biologic Therapies webcast series that provides clinicians with a review of the use of biologic agents in the fields of rheumatology, dermatology, allergy, and infectious disease. This series is especially beneficial for physicians and mid-level providers who lack direct resources in biologic therapy education. It will broaden the knowledge base of health care professionals and enhance their ability to create management strategies and improve the care of their patients.
Biologic Therapies VII: Precision Medicine in the Biologic Era
Cleveland Clinic R.J. Fasenmyer Center for Clinical Immunology presents Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.
E-Journal Club: Advances in Therapy and Pathogenesis of Rheumatic Diseases
This E-Journal Club: Advances in Therapy and Pathogenesis of Rheumatic Diseases educational series will engage rheumatologists, primary care physicians, and other interested clinicians in an examination, discussion, and assessment of the most recent peer-reviewed literature on rheumatic diseases. Dr. Leonard Calabrese will lead an interactive discussion with the lead author of a top evidence-based journal article. Together they will filter, synthesize, and translate the key points into clinical pearls that can be applied to the clinician practice. Commentary on emerging management strategies to improve patient function, care, and quality of life will be provided by the article author.
Primary Vasculitides: Best Practices and Future Advances
Cleveland Clinic R.J. Fasenmyer Center for Clinical Immunology presents Primary Vasculitides: Best Practices and Future Advances online series featuring an update on the current standard of care and management of patients with primary vasculitides. Advances and future development in the treatment of primary vasculitides will be shared by the experts in this field.